NLP Flower

Roll over and click to learn more

Gain access to critical insights from early research through clinical, medical affairs analytics, brand launch and beyond.

Understand the full landscape of your product portfolio.

• Evaluate the richness and density of evidence, so you can manage stakeholder expectations and allocate the right budget and resources to answer key questions in the optimal way • Rapidly identify data points that reveal the one table or value you need, instead of sifting through hundreds of research papers to find it

Epidemiology research, disease surveillance and monitoring

• Reduce the cost and timelines of clinical research by identifying and using existing research more effectively • Leverage data about existing research to better design your clinical studies to improve recruitment and focus on the patient cohorts that will yield the best outcomes

Clinical insights

• Identify previously unknown relationships between biomarkers and disease profiles • Plot evidence density against pre-defined patient dimensions such as age or disease profile • Quickly identify sources that provide evidence for multiple biomarkers and phenotypic indicators of interest

Genomic and biomarker insights

• Continuously monitor for new clinical trials that may be relevant for drug repurposing in your disease area, prioritized by how closely the results match your focus areas • Identify competitive activity from across published, grey and clinical development documents, ranked by competitive risk factors to help you react quickly and effectively to changes in the market

Drug development strategic insights

• Respond rapidly to patient issues that arise in the real-world setting • Enhance your understanding of adherence and likely product switching by tracking what patients and caregivers say online over time • Be the first to respond with robust scientific information and timely investments in risk mitigation activity

Voice of patient, customer, caregiver and advocacy group

• Build a compelling view of target KOLs for collaboration based on the details of their research activities • Continuously monitor health authorities, regulators, providers and other institutions to ensure you are kept abreast of the latest developments

Voice of stakeholder and institution (including KOL insights)

• Extract key topics and themes and normalize the data to measure effectiveness and impact of MSL messaging and education • Align your own external content generation to the hot topics that are most important to HCPs

MSL and HCP interaction insights

NLP Insights Hub

Epidemiology research, disease surveillance and monitoring

Clinical insights

Genomic and biomarker insights

Drug development strategic insights

Voice of patient customer, caregiver and advocacy group

Voice of stakeholder and institution (incl. KOL insights)

MSL and HCP interaction insights

NLP Insights Hub

Epidemiology research, disease surveillance and monitoring

Clinical insights

Genomic and biomarker insights

Drug development strategic insights

Voice of patient customer, caregiver and advocacy group

Voice of stakeholder and institution (incl. KOL insights)

MSL and HCP interaction insights

NLP Insights Hub

Roll over and click to learn more

Next >

< Back

Next >

< Back

Next >

< Back

Next >

< Back

Next >

< Back

Next >

< Back